Outcomes of bictegravir/emtricitabine/tenofovir alafenamide versus efavirenz-based regimens in central China: a real-world assessment

被引：1
|
作者：
Peng, Yongquan [1 ]
Cao, Xujian [1 ]
Wang, Yating [1 ]
Yu, Weiwei [2 ]
Zeng, Ziwei [2 ]
Wang, Min [2 ]
机构：
[1] Univ South China, Hosp Changsha 1, Grad Collaborat Training Base, Grad Collaborat Training Base, Hengyang 421001, Hunan, Peoples R China
[2] First Hosp Changsha, Inst HIV AIDS, Changsha 410000, Hunan, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2023年 / 136卷 / 22期
关键词：
D O I：
10.1097/CM9.0000000000002888
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2738 / 2740
页数：3
相关论文
共 50 条
  • [31] Associations with weight change and patient-reported outcomes after switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF)
    Lowman, E.
    Unger, N.
    Hardigan, P. C.
    Lee, N.
    HIV MEDICINE, 2020, 21 : 20 - 20
  • [32] Assessment of risk factors for virological nonsuppression following switch to dolutegravir and lamivudine, or bictegravir, emtricitabine, and tenofovir alafenamide fumarate in a real-world cohort of treatment-experienced adults living with HIV
    Lee, Shu-Yuan
    Lin, Yi-Chun
    Chen, Cheng-Pin
    Cheng, Shu-Hsing
    Chang, Shu-Ying
    Ku, Shin-Yen
    Cheng, Chien-Yu
    PLOS ONE, 2024, 19 (11):
  • [33] Comparing the long-term effectiveness and safety of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate as first-line regimens: a real life multicentre cohort
    Ciccullo, Arturo
    Baldin, Gianmaria
    Cervo, Adriana
    Moschese, Davide
    Lagi, Filippo
    Cossu, Maria Vittoria
    Grimaldi, Alessandro
    Giacomelli, Andrea
    Rusconi, Stefano
    Sterrantino, Gaetana
    Borghetti, Alberto
    Antinori, Spinello
    Mussini, Cristina
    Di Giambenedetto, Simona
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 80 (01) : 175 - 177
  • [34] Treatment persistence of bictegravir/emtricitabine/tenofovir alafenamide and efavirenz plus lamivudine plus tenofovir disoproxil among HIV-1 patients newly starting treatment in Hunan Province in China
    Cao, Jing
    Tang, Wei
    Wang, Ning
    Zheng, Fang
    Xiao, Gang
    Wang, Xingzhi
    Zhou, Guoqiang
    Wang, Min
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [35] Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV
    De Socio, Giuseppe Vittorio
    Tordi, Sara
    Altobelli, Debora
    Gidari, Anna
    Zoffoli, Anastasia
    Francisci, Daniela
    Wozniacka, Anna
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
  • [36] Effectiveness of Bictegravir/ Emtricitabine/Tenofovir Alafenamide(BIC/FTC/ TAF) as switch strategy in virologically suppressed: Real world data from monocentric cohort
    Passerotto, R. A.
    Lamanna, F.
    Farinacci, D.
    Dusina, A.
    D'Angelillo, A.
    Ciccullo, A.
    Baldin, G.
    Mozzetta, I.
    Visconti, E.
    Di Giambenedetto, S.
    Borghetti, A.
    HIV MEDICINE, 2023, 24 : 139 - 140
  • [37] Effectiveness of Bictegravir/ Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) in treatment-experienced people with HIV using real-world data: A systematic review and meta-analysis
    Chivite, I.
    Berrocal, L.
    De lazzari, E.
    Navadeh, S.
    Lluis, C.
    Inciarte, A.
    De la Mora, L.
    Gonzalez-Cordon, A.
    Martinez-Rebollar, M.
    Laguno, M.
    Torres, B.
    Blanco, J. L.
    Martinez, E.
    Mallolas, J.
    Ambrosioni, J.
    HIV MEDICINE, 2023, 24 : 70 - 71
  • [38] Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis
    Chivite, Ivan
    Berrocal, Leire
    de Lazzari, Elisa
    Navadeh, Soodabeh
    Lluis-Ganella, Carla
    Inciarte, Alexy
    de la Mora, Lorena
    Gonzalez-Cordon, Ana
    Martinez-Rebollar, Maria
    Laguno, Montserrat
    Torres, Berta
    Blanco, Jose Luis
    Martinez, Esteban
    Mallolas, Josep
    Ambrosioni, Juan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (08) : 1775 - 1783
  • [39] Bictegravir-based antiretroviral therapy in HIV-1 group O patients: data from real-life bictegravir/emtricitabine/tenofovir alafenamide switches
    Martin, Charlene
    Unal, Guillemette
    Plantier, Jean-Christophe
    Alessandri-Gradt, Elodie
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (08) : 2305 - 2307
  • [40] Real-world assessment of renal safety among patients with HIV infection exposed to tenofovir alafenamide
    Megarity, S.
    Rafferty, P.
    Dinsmore, W.
    Donnelly, C.
    Emerson, C.
    McCarty, E.
    Quah, S.
    HIV MEDICINE, 2017, 18 : 44 - 44
12345